Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221694 | SCV000273105 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000459891 | SCV000556657 | likely benign | Tuberous sclerosis 2 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001582740 | SCV001811005 | likely benign | not provided | 2020-02-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000459891 | SCV002039892 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494581 | SCV002801156 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-02-11 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997768 | SCV004830190 | likely benign | Tuberous sclerosis syndrome | 2023-06-08 | criteria provided, single submitter | clinical testing |